Est. Since
2009

12

Years of Experience

40

Pivotal Projects

8,000

Volunteers

300

Investigators

40

Audits with no Critical Finding

Eminent International Advisory Panel

PROFESSOR DAVID LALLOO

Director Liverpool School of Tropical Medicine and Professor of Tropical Medicine

PROFESSOR JANE ARMITAGE

Professor of Clinical Trials and Epidemiology and Honorary Consultant in Public Health Medicine in the Nuffield Department of Population Health (NDPH) at the University of Oxford

PROFESSOR ANUSHKA PATEL

Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia

Hands on Leadership

Samantha Ranatunga

CEO/Director

Dr. Namal Wijesinghe

Consultant/ Head of Clinical Operations

Chanaka Fernando

General Manager – Finance & Administration

Anuradha Dahanayaka

Senior Manager – Clinical Operations

Thanush Jeevarajah

Senior Manager – Business Development & Regulatory

Ingrid de Silva

Manager – Administration

Shalomi Weerawardena

Manager – Compliance & Quality Assurance

Isuru Edirisinghe

Manager – Human Resources

Rajeewa Perera

Manager – Facilities Management

Upul Ratnayaka

Manager – Information Technology

View More

Therapeutic Expertise

Oncology

Oncology

Read more

Endocrinology

Endocrinology

Read more

Immunology

Immunology

Read more

Neurology

Neurology

Read more

Gastroenterology

Gastroenterology

Read more

Cardiology

Cardiology

Read more

Ophthalmology

Ophthalmology

Read more

Toxicology

Toxicology

Read more

Infectious Diseases

Infectious-Diseases

Read more

Rare Diseases

Rare Diseases

Read more

View More

Rare Diseases

As per WHO definition a rare disease affects 1 in 2000 or fewer. There are more than 7000 rare diseases identified and most of them are linked to genetic disorders. In Sri Lanka, it is estimated that more than 2 million people live with rare diseases.

December 21, 2022

Hope for Cure. Issue 2.0

“Hope for Cure” is a quarterly bulletin focusing on rare diseases in Sri Lanka. RemediumOne as a clinical research organisation hopes to bring Sri Lankan expertes who treats orphan diseases in Sri Lanka and the […]

Read More

June 13, 2022

Rare Diseases Bulletin V 1.0 I 1.0

“Hope for Cure” is a quarterly bulletin focusing on rare diseases in Sri Lanka. RemediumOne as a clinical research organisation hopes to bring Sri Lankan expertes who treats orphan diseases in Sri Lanka and the […]

Read More

February 5, 2022

Acromegaly

The prevalence of acromegaly in Sri Lanka is estimated 5 in 100,000 population [Population of Sri Lanka 23 million]. Majority (90%) of the patients have facial and acral changes at the time of diagnosis. 80% […]

Read More

Audits & Updates

Explore All

FDA Readiness Programme

RemediumOne organised a FDA Readiness Programme for the Investigators whom we are working with. Madline Ducatte from UK conducted the training. Madline has extensive and global experience in facing FDA audits. 

Read More

February 4, 2022

First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne

First Sri Lankan ACRP (Association for Clinical Research Professionals, USA) certified CRA from RemediumOne RemediumOne is proud to announce that the country’s first ACRP (Association of Clinical Research Professionals, USA) certified CRA is from RemediumOne. […]

Read More

February 3, 2022

Virtual Audit at RemediumOne

RemediumOne faced an audit carried out by the sponsor for one of its more complex and pivotal studies. It was the first experience for the company with a virtual audit carried out through an online […]

Read More

Our Collaborators

Investigators & Site Network

Investigators

Explore All

January 14, 2023

Engagement with clinical teams at Kandy National Hospital. Clinical trial conduct in Sri Lanka.

A sucessfull engagement program was completed on 14 January 2023. RemediumOne team met key clinical team at Kandy Teaching Hospital discussion participant centric clinical trial conduct in Sri Lanka. https://www.linkedin.com/company/7121876/admin/

Read More

December 2, 2022

Clinical Trial (Research) in Sri Lanka – ENRICH AF

ENRICH AF is investigating whether edoxaban (60/30 mg daily) compared to non-antithrombotic medical therapy (either no antithrombotic therapy or antiplatelet monotherapy) reduces the risk of stroke (composite of ischemic, hemorrhagic and unspecified stroke) in high-risk […]

Read More

November 15, 2022

Clinical Research / Clinical Trial in Sri Lanka: Advancing Evidence for the Global Implementation of Spatial Repellents (AEGIS) Project in Sri Lanka

Advancing Evidence for the Global Implementation of Spatial Repellents (AEGIS) Project in Sri Lanka The AEGIS project will generate further evidence about spatial repellents, a mosquito control product with the potential to dramatically improve malaria […]

Read More

Site Network

Explore All

February 3, 2022

Tertiary care hospitals in Sri Lanka

Large, well-equipped, tertiary-care hospitals compatible with those in developed countries with all major and subspecialties. Main function of these tertiary care hospitals is to provide curative services. Being attached to medical schools of Sri Lanka, […]

Read More

February 2, 2022

Specialty treatment centers in Sri Lanka – National Cancer Institute, Maharagama

The National Cancer Institute (Apeksha Hospital/ (NCI) is the leading hospital under the Ministry of Health. The NCI offers both the diagnostic facilities necessary for the identification of all types of cancer, and specialized care […]

Read More

February 1, 2022

Clinical research site at The National Hospital of Sri Lanka

The National Hospital of Sri Lanka (NHSL) situated in Colombo in a 32-acre block of land is the largest teaching hospital in Sri Lanka and the final referral center in the country consisting of 3000 […]

Read More

Employee Engagement

October 14, 2022

Execution excellence through self-leadership Staff training programme

Big thanks to Wild Drift – Professionals in training and coaching. RemediumOne empowers staff through continuous training. Learning and development plays major role in successful delivery of our work. Quarterly engagements similar in nature with Wild […]

Read More

June 17, 2022

Leadership Training at Belihuloya

Provided leadership training for our staff at Belihuloya with Wild Drift team. Had a productive two days and refreshed our mind and soul through the training.

Read More

June 15, 2022

Reaching Above and Beyond – The first staff meeting of the year 2022

After 8 months Remedians gathered together in April 2022 to review the organisational progress and to discuss the future prospects. It was a thoughtful and successful event with fun filled evening. Glimpse of staff gathering […]

Read More

Latest News

Explore All

February 2, 2023

Largest meet for clinical research professionals in South Asia

Indian Society for Clinical Research (ISCR) annual meet is the largest single event for clinical researchers in South Asia. RemediumOne is always delighted to partner with ​Indian Society for Clinical Research. 16th annual conference of […]

Read More

December 23, 2022

Advancing Evidence for Global Implementation of Spatial Repellents – Social sciences component

John Hopkins Centre for Communications Program (CCP) and the Department of International Health at the Johns Hopkins School of Public Health (JHSPH) are leading the social science portion of a five-year, $33.7 million grant from […]

Read More

November 29, 2022

Takeda Dengue Vaccine Listing [Clinical trials in Sri Lanka]

The European Medicines Agency’s (EMA) Human Medicines Committee (CHMP) has recommended the use of Takeda’s Dengue Tetravalent Vaccine, to prevent disease caused by dengue virus serotypes 1, 2, 3 and 4 in people from four […]

Read More

Publications

Explore All

View Publication

July 29, 2022

Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South AsianWomen With Recent Gestational Diabetes

View Publication

July 25, 2022

Desidustat in Anemia due to Non- Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)

View Publication

July 18, 2022

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

View Publication

July 12, 2022

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

View Publication

February 7, 2022

Polypills for the prevention of cardiovascular disease: a framework for wider use

View Publication

February 6, 2022

Effcay of a Tetravalent Dengue Vaccine in Healthy Children & Adolescents

View Publication

February 5, 2022

A Community-Based Intervention for Managing Hypertension in Rural South Asia